FDMT — 4D Molecular Therapeutics, Inc. stock price, charts and financials

QT744D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.14
+0.39+3.63%
OverviewShort InterestFilings
FDMTQT744D Molecular Therapeutics, Inc.·NASDAQ
11.14+3.63%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 05, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Jul 20, 20268-KCurrent report
Jul 14, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 25, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 22, 20268-KCurrent report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 2026EFFECTNotice of effectiveness
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 07, 2026S-3Shelf registration statement
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
Apr 28, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 317
Page
▼
/ 13